3543-74-6 Ethyl 4-{5-[Bis-(2-hydroxy-ethyl)-amino]-1-methyl-1H-benzoimidazol-2-yl}-butyrate 98%

Myosynth Laboratories，established in 2018, is a pharmaceutical company located inVisakhapatnam (Vizag),Andhra Pradesh, India.The company specializes in the manufacturing ofActive Pharmaceutical Ingredients (APls) and intermediates. With a production capacity of 70 KL,Myosynth Laboratories has positioned itself as a significant player in the pharmaceutical industry.One of the key strengths of Myosynth Laboratories is its extensive range of drug licenses. Thecompany holds licenses for 32 Oncology APIs, demonstrating its focus on addressing criticalmedical needs in the field of cancer treatment.Additionally, the company has obtained licensesfor eight latest APls,indicating its commitment to staying at the forefront of pharmaceuticalinnovation.
Myosynth Laboratories boasts a state-of-the-art analytical laboratory equipped with advancedtesting facilities.This allows the company to ensure the quality and efficacy of its products. With adedicated research and development center,Myosynth Laboratories is continuously engaged inexploring and discovering new chemical entities. By investing in research, the company aims todevelop cost-effective processes and deliver high-quality products to meet the needs of patientsat affordable prices.